Why do we need the CARDia trial?

May 2003    Volume 10, Issue 2   Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 37–AIC 40

Authors:
Akhil Kapur, Kevin J Beatt

The Coronary Artery Revascularisation in Diabetes (CARDia) trial is an investigator-initiated study and is the first prospective study designed specifically to address the hypothesis that optimal percutaneous coronary intervention (PCI) with stenting and abciximab is not inferior to up-to-date coronary artery bypass grafting (CABG) as a revascularisation strategy for diabetics with multivessel or complex single vessel coronary disease.

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top